From: Clinical and laboratory evaluation of new immigrant and refugee children arriving in Greece
Total N (%) | I N = 138 (46) | R N = 162 (54) | p-value | |
---|---|---|---|---|
Gender | ||||
M/F | 176/124 (58.7/41.3) | 86/52 (62.3/37.5) | 90/72 (55.6/44.4) | 0.236 |
Mean age (SD), years | 7.08 (3.8) | 6.3 (3.8) | 7.8 (3.7) | 0.001 |
Geographic area of origin | ||||
Europe | 29 (9.7) | 29(21.0) | 0 (0.0) | <0.001 |
Africa | 29 (9.7) | 14 (10.1) | 15 (9.3) | |
Asia | 242 (80.7) | 95 (68.8) | 147 (90.7) | |
BMI (Median (IQR)a | 15.7 (2.7) | 15.5 (3.1) | 0.886 | |
Anemia b | 41 (13.7) | 21 (15.2) | 20 (12.3) | 0.470 |
Pb (≥5 μg/ dl)c | 72 (30.6) | 45 (37.2) | 27 (23.7) | 0.025 |
Ferritin (≤12 ng/l) | 50 (17.3) | 30 (22.1) | 20 (13.1) | 0.044 |
Eosinophilia (≥450mm3) | 68 (22.7) | 35 (25.4) | 33 (20.4) | 0.303 |
Vaccination status (unknown) | 238 (79.3) | 90 (65.2) | 148 (91.4) | <0.001 |
BCG (records/scar) | 262 (87.3) | 115 (83.3) | 147(90.7) | 0.055 |
Mantoux ≥ 10 mm | 8 (2.7) | 0(0.0) | 8 (4.9) | 0.008 |
HBV serology | ||||
anti-HBs (+) | 173 (57.7) | 90 (65.2) | 83 (51.2) | 0.015 |
anti-c (+) | 0 (0.0) | 0 (0.0) | 0 (0,0) | |
HbsAg (+) | 0 (0.0) | 0 (0.0) | 0 (0,0) | |
HCV serology | ||||
anti- HCV (+) | 1 (0.6) | 0 (0.0) | 1 (0.6) | 0.365 |